Search Results

You searched for : LatestMerckNews  

Merck Announces U.S. FDA Approval of VAXNEUVANCE for the Prevention of Invasive Pneumococcal Disease in Adults 18 Years and Older

Pneumococcal disease is an infection caused by bacteria called Streptococcus pneumoniae, or pneumococcus....
Jul 17

LYNPARZA (olaparib) Approved in China for the Treatment of Certain Patients with BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

Only PARP Inhibitor to Demonstrate Overall Survival Versus New Hormonal Treatments in BRCA1/2-Mutated Advanced Prostate Cancer...
Jun 24

Merck to Participate in the Guggenheim Biopharma Strategy Series

Merck Research Laboratories, is scheduled to participate in a virtual fireside chat at the Guggenheim Biopharma Strategy Series...
Jun 19

Merck Announces Supply Agreement with U.S. Government for Molnupiravir

...
Jun 09

U.S. FDA Accepts for Priority Review the Biologics License Application for V114

Merck announced the U.S. FDA accepted for priority review a Biologics License Application for V114, Merck’s investigational 15-valent pneumococcal conjugate vaccine, for ...
Jan 12

LYNPARZA (olaparib) Receives Three New Approvals in Japan

LYNPARZA has been approved in Japan for the treatment of three types of advanced cancer: ovarian, prostate and pancreatic cancer....
Dec 28

Merck Announces Supply Agreement with U.S. Government for Initial Doses of Investigational Biological Therapy for the Treatment of COVID-19

...
Dec 23

FDA Grants Priority Review to Merck’s Supplemental Biologics License Application for KEYTRUDA

...
Dec 18

FDA Grants Priority Review to Merck’s Supplemental Biologics License Application for KEYTRUDA

Patients with newly diagnosed esophageal and GEJ cancer face an aggressive disease with a poor prognosis, despite the currently available treatment options...
Dec 17

KEYTRUDA Plus LENVIMA Combination Demonstrated Statistically Significant Improvement in Overall Survival

...
Dec 16

Merck Receives Positive EU CHMP Opinion for KEYTRUDA as First-Line Treatment for Metastatic Microsatellite Instability

...
Dec 11

Merck Submits Applications for Licensure of V114, the Company’s Investigational 15-valent Pneumococcal Conjugate Vaccine

...
Nov 23

Acquisition adds to Merck’s suite of clinical programs in response to SARS-CoV-2/COVID-19

Meaningful new therapeutic options are desperately needed for possibly millions of people around the world who will develop severe or critical COVID-19 disease...
Nov 23

Merck Advances Phase 3 Trial to Evaluate Investigational Islatravir as Once-Monthly Oral PrEP for Women at High Risk for Acquiring HIV-1

Collaboration with the Bill & Melinda Gates Foundation Seeks to Bring Forward a New HIV Prevention Option with Focus on Women...
Nov 16

KEYTRUDA plus LENVIMA met the trial’s primary endpoint of progression-free survival

LENVIMA plus everolimus were evaluated versus sunitinib for the first-line treatment of patients with advanced renal cell carcinoma...
Nov 10

LYNPARZA Approved in the EU for Treatment of BRCA1/2-Mutated Metastatic Castration-Resistant Prostate Cancer

Only PARP Inhibitor to Demonstrate Overall Survival Versus New Hormonal Agent Treatments in BRCA1/2-Mutated mCRPC...
Nov 05

Merck Donates $500,000 to Support River Blindness and Lymphatic Filariasis Elimination Efforts

Merck and the MECTIZAN Donation Program, announced today a $500,000 cash donation to support NGO partners working to eliminate onchocerciasis and lymphatic filariasis...
Oct 22

Merck Announces Positive Topline Results from Two Additional Phase 3 Adult Studies Evaluating V114, Merck’s Investigational 15-valent Pneumococcal Conjugate Vaccine

Pneumococcal disease in adults is on the rise globally, in part driven by disease-causing serotypes not targeted by the currently available pneumococcal conjugate vaccine...
Oct 21

FDA Approves Expanded Indication for Merck’s KEYTRUDA in Adult Patients With classical Hodgkin Lymphoma (cHL)

...
Oct 15

Merck Announces Week 96 Data from Phase 2b Study Evaluating Islatravir With Doravirine for HIV-1

Merck, today announced Week 96 data from the Phase 2b trial evaluating the efficacy and safety of islatravir for HIV-1 infections...
Oct 08

Merck Animal Health Supports Rabies Elimination by 2030 on World Rabies Day

Merck Animal Health announced the launch of a global campaign to raise awareness among veterinarians, dog owners and volunteers who are committed to eliminate rabies ...
Sep 28

21 Matching result(s) found!

-Advertisements-




Trending Now

Moscow Outpatient Departments to Implement AI X-ray InterpretationMay 31, 2024
FLO launched Digital Ready Reckoner - of MSME schemes.May 31, 2024
Candy flavoured traps to hook the next generationMay 31, 2024
Software Engineering Research Centre (SERC) at IIIT H to host 21st Edition of IEEE International Conference on Software Architecture (ICSA) 2024May 31, 2024
Federal Bank and Tata AIA Life Insurance Announce Strategic Bancassurance PartnershipMay 31, 2024
Why Whole Spices are Better than Powdered: New ICMR GuidelinesMay 31, 2024
Raising Awareness on Menstrual Health: NCW and SheWings Initiative on Menstrual Hygiene DayMay 31, 2024
Innovative RNA Drugs Offer Hope for Patients with High CholesterolMay 31, 2024
Advani Hotels & Resorts (India) Limited (Caravela Beach Resort, Goa)May 30, 2024
FLO Hyderabad launches ‘Centre of Excellence for Training Women Vegetable Farming’May 30, 2024
Should Doctors Be Exempt from the Consumer Protection Act? A Complex DebateMay 30, 2024
Tamil Nadu Doctors Save 14-Year-Old Girl by Removing Needle from Lung with BronchoscopyMay 30, 2024
The Lifesaving Journey of a Florist: Rare 'Bombay' Blood Group Donation Saves Life May 30, 2024
The Impact of Heat on Eye Health: Preventing Eye Strokes During High TemperaturesMay 30, 2024
Patients with super morbid obesity can find life-changing benefits beyond weight reduction through bariatric surgeryMay 29, 2024
AI software could revolutionise voice box cancer treatmentMay 29, 2024
Why You’re Waking Up to Pee: The Link Between Enlarged Prostate and NocturiaMay 29, 2024
Rising Smoking Rates Among Teenage Girls: A Growing Health Crisis in IndiaMay 29, 2024
WHO Launches $7 Billion Investment Round at the 77th World Health AssemblyMay 29, 2024
From Insulin-Dependent to Insulin-Free in just 3 months: Game-Changing Diabetes Cure Developed by Chinese ScientistsMay 29, 2024